Oncaspar (Generic Pegaspargase ) is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation
Oncaspar (Pegaspargase) Uses and Indications:
ONCASPAR (pegasapragase) is indicated as a component of multi-agent chemotherapeutic regimen for treatment of patients with:
- First-line Acute Lymphoblastic Leukemia (ALL)
- ALL and hypersensitivity to native forms of L-asparaginase.
Common side effects of ONCASPAR (pegasapragase) includes:
Allergic reactions (including anaphylaxis), hyperglycemia, pancreatitis, central nervous system (CNS) thrombosis, coagulopathy, hyperbilirubinemia, and elevated transaminases.
DOSAGE FORM & STRENGTH:
- Oncaspar (Pegaspargase) Injection (750 Inter. Units. Per mL) wholesaler, supplier, Distributor
Rasso Swiss Pharma is a Oncaspar (Pegaspargase) distributor, wholesaler and supplier.